Latest Insider Transactions at Vaxart, Inc. (VXRT)
This section provides a real-time view of insider transactions for Vaxart, Inc. (VXRT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vaxart, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vaxart, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2022
|
James F. Cummings Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,750
+50.0%
|
-
|
|
Jan 10
2022
|
Robert A. Yedid Director |
SELL
Open market or private sale
|
Indirect |
1,500
-100.0%
|
$9,000
$6.01 P/Share
|
|
Dec 22
2021
|
Todd C Davis Director |
SELL
Bona fide gift
|
Direct |
1,470
-1.23%
|
-
|
|
Nov 30
2021
|
Margaret Echerd SVP, Principal Accntng Officer |
SELL
Open market or private sale
|
Direct |
3,602
-100.0%
|
$28,816
$8.0 P/Share
|
|
Nov 30
2021
|
Margaret Echerd SVP, Principal Accntng Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,602
+47.45%
|
$7,204
$2.97 P/Share
|
|
Oct 12
2021
|
Robert A. Yedid Director |
BUY
Bona fide gift
|
Indirect |
1,500
+50.0%
|
-
|
|
Oct 12
2021
|
Robert A. Yedid Director |
SELL
Bona fide gift
|
Direct |
4,500
-23.03%
|
-
|
|
Sep 10
2021
|
Margaret Echerd SVP, Principal Accntng Officer |
SELL
Open market or private sale
|
Direct |
1,801
-100.0%
|
$16,209
$9.1 P/Share
|
|
Sep 10
2021
|
Margaret Echerd SVP, Principal Accntng Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,801
+47.44%
|
$3,602
$2.97 P/Share
|
|
Aug 10
2021
|
Margaret Echerd SVP, Principal Accntng Officer |
SELL
Open market or private sale
|
Direct |
1,801
-100.0%
|
$18,010
$10.0 P/Share
|
|
Aug 10
2021
|
Margaret Echerd SVP, Principal Accntng Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,801
+47.45%
|
$3,602
$2.97 P/Share
|
|
Aug 10
2021
|
Sean Tucker SVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
5,828
-10.17%
|
$58,280
$10.2 P/Share
|
|
Aug 10
2021
|
Sean Tucker SVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,172
-8.68%
|
$41,720
$10.2 P/Share
|
|
Jul 19
2021
|
Margaret Echerd SVP, Principal Accntng Officer |
SELL
Open market or private sale
|
Direct |
1,800
-100.0%
|
$14,400
$8.0 P/Share
|
|
Jul 19
2021
|
Margaret Echerd SVP, Principal Accntng Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,800
+47.45%
|
$3,600
$2.97 P/Share
|
|
Jun 18
2021
|
Michael J. Finney Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
181,818
+21.7%
|
$181,818
$1.1 P/Share
|
|
Jun 18
2021
|
Michael J. Finney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
21,700
+2.26%
|
$0
$0.68 P/Share
|
|
Jun 11
2021
|
Margaret Echerd SVP, Principal Accntng Officer |
SELL
Open market or private sale
|
Direct |
1,802
-100.0%
|
$14,416
$8.0 P/Share
|
|
Jun 11
2021
|
Margaret Echerd SVP, Principal Accntng Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,802
+47.45%
|
$3,604
$2.97 P/Share
|
|
Jun 11
2021
|
Robert A. Yedid Director |
SELL
Open market or private sale
|
Direct |
10,000
-54.82%
|
$80,000
$8.61 P/Share
|
|
Jun 11
2021
|
Robert A. Yedid Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,240
+50.0%
|
$0
$0.31 P/Share
|
|
Jun 09
2021
|
Margaret Echerd SVP, Principal Accntng Officer |
SELL
Open market or private sale
|
Direct |
47,555
-100.0%
|
$380,440
$8.0 P/Share
|
|
Jun 09
2021
|
Margaret Echerd SVP, Principal Accntng Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,555
+46.28%
|
$95,110
$2.97 P/Share
|
|
May 07
2021
|
Wouter Latour Director |
SELL
Open market or private sale
|
Direct |
100,000
-100.0%
|
$700,000
$7.13 P/Share
|
|
May 07
2021
|
Wouter Latour Director |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+50.0%
|
$100,000
$1.7 P/Share
|
|
May 06
2021
|
Wouter Latour Director |
SELL
Open market or private sale
|
Direct |
100,000
-100.0%
|
$600,000
$6.54 P/Share
|
|
May 06
2021
|
Wouter Latour Director |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+50.0%
|
$100,000
$1.7 P/Share
|
|
Mar 16
2021
|
Sean Tucker SVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,006
+2.05%
|
$6,036
$6.49 P/Share
|
|
Mar 04
2021
|
Wouter Latour Director |
SELL
Open market or private sale
|
Direct |
150,000
-100.0%
|
$900,000
$6.04 P/Share
|
|
Mar 04
2021
|
Wouter Latour Director |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+50.0%
|
$0
$0.77 P/Share
|
|
Nov 23
2020
|
Wouter Latour Director |
SELL
Open market or private sale
|
Direct |
333,334
-100.0%
|
$2,000,004
$6.32 P/Share
|
|
Jun 29
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 29
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Direct |
9,385,386
-98.47%
|
$75,083,088
$8.29 P/Share
|
|
Jun 29
2020
|
Armistice Capital, LLC Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
0
|
-
|
|
Jun 29
2020
|
Armistice Capital, LLC Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
4,090,909
+30.03%
|
$4,090,909
$1.1 P/Share
|
|
Jun 26
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 26
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Direct |
18,226,667
-77.01%
|
$182,266,670
$10.38 P/Share
|
|
Jun 26
2020
|
Armistice Capital, LLC Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
0
|
-
|
|
Jun 26
2020
|
Armistice Capital, LLC Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
16,666,667
+41.32%
|
$0
$0.3 P/Share
|
|
Jun 03
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 03
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Direct |
400,000
-5.41%
|
$800,000
$2.77 P/Share
|
|
Jun 02
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 02
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Direct |
800,000
-9.76%
|
$1,600,000
$2.75 P/Share
|
|
Jun 01
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jun 01
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Direct |
200,000
-2.38%
|
$400,000
$2.74 P/Share
|
|
May 27
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
May 27
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Direct |
200,000
-2.33%
|
$400,000
$2.61 P/Share
|
|
May 22
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
May 22
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Direct |
200,000
-2.27%
|
$400,000
$2.86 P/Share
|
|
May 21
2020
|
Armistice Capital, LLC Director |
SELL
Open market or private sale
|
Indirect |
0
|
-
|